Palisade Bio
Price & Volume
Stats
See more52W Range | $0.53-$3.30 |
Market Cap | $318.8M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.07 |
News
See moreYahoo Finance • 22 days ago
Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations
Yahoo Finance • 30 days ago
Palisade Bio Announces First Patients Dosed in Phase 1b Study of Oral First-In-Class PDE4 Inhibitor Prodrug, PALI-2108, for the Treatment of Fibrostenotic Crohn’s Disease (FSCD)
Yahoo Finance • last month
Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108
Yahoo Finance • last month
Palisade Bio Announces Cancellation of Special Meeting of Stockholders
About
CEO | Mr. J. D. Finley |
CFO | Mr. J. D. Finley |
Address | 7750 El Camino Real, Carlsbad, CA, United States, 92009 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 8 |
